Impact of vaccines on antimicrobial resistance

Area of Science:

• Microbiology
• Infectious Diseases
• Public Health

Background:

• Antibiotic use is a primary driver of antimicrobial resistance (AMR), a significant global health concern.
• Increased antibiotic use in humans, livestock, and agriculture, coupled with misuse and under-development of new antibiotics, exacerbates the AMR crisis.
• AMR threatens global health, increases mortality, raises healthcare costs, and jeopardizes routine medical procedures.

Purpose of the Study:

• To explore the potential of vaccines as a tool to combat antimicrobial resistance (AMR).
• To review how vaccine technology can be leveraged to decrease the incidence and spread of resistant infections.
• To discuss the role of vaccines in reducing overall antibiotic consumption and preventing the emergence of antibiotic-resistant bacteria.

Main Methods:

• Literature review of existing research on antimicrobial resistance (AMR) and vaccine development.
• Analysis of how vaccines prevent infections, thereby reducing the need for antibiotic treatment.
• Examination of the impact of vaccines on preventing the development and spread of antibiotic-resistant infections.

Main Results:

• Vaccines can decrease AMR by preventing both bacterial and viral infections, leading to reduced antibiotic use and misuse.
• Vaccination strategies can prevent the establishment and transmission of antibiotic-resistant bacterial infections.
• Vaccines are generally less likely to induce antimicrobial resistance compared to antibiotics.

Conclusions:

• Vaccines represent a crucial complementary strategy to traditional approaches in reducing AMR.
• Preventing infections through vaccination directly lowers antibiotic consumption and the selective pressure driving resistance.
• Continued investment in novel vaccine and drug development is essential for effectively mitigating the global threat of AMR.